As part of the agreement, Clinique will be responsible for formulating, developing and manufacturing the new product line. Clinique will sell products to Allergan, while Allergan will record sales to physicians and handle consumer and professional marketing and distribution. Clinique and Allergan may also conduct clinical trials and work with the physician community to ensure the success of the new skin care line.
“In collaboration with Clinique, our goal is to establish a leadership position in physician-dispensed skin care by offering a one-stop approach to specialized skin care products under a brand name that is trusted by consumers and backed by science on which physicians can rely,” said David E.I. Pyott, Allergan’s chairman of the board and chief executive officer.
“Clinique’s rich dermatological heritage dates back 40 years,” said William P. Lauder, president and chief executive officer, The Estée Lauder Companies Inc. “This new skin care line, created in collaboration with Allergan, is the next generation of the expression of Clinique’s unique position delivered through one of the fastest growing channels today, physicians’ offices.”